A Study of Advanced or Metastatic Non-small Cell Lung Cancer

NCT00988858 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: LY2603618
DRUG: Pemetrexed

Sponsor

Eli Lilly and Company